<SEC-DOCUMENT>0001965301-24-000167.txt : 20241226
<SEC-HEADER>0001965301-24-000167.hdr.sgml : 20241226
<ACCEPTANCE-DATETIME>20241226161458
ACCESSION NUMBER:		0001965301-24-000167
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20241226
DATE AS OF CHANGE:		20241226

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Roivant Sciences Ltd.
		CENTRAL INDEX KEY:			0001635088
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				981173944
		STATE OF INCORPORATION:			D0
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-40782
		FILM NUMBER:		241581246

	BUSINESS ADDRESS:	
		STREET 1:		CLARENDON HOUSE, 2 CHURCH STREET
		CITY:			HAMILTON HM11
		STATE:			D0
		ZIP:			HM11
		BUSINESS PHONE:		441-295-5950

	MAIL ADDRESS:	
		STREET 1:		CLARENDON HOUSE
		STREET 2:		2 CHURCH STREET
		CITY:			HAMILTON
		STATE:			D0
		ZIP:			HM11

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sukhatme Mayukh
		CENTRAL INDEX KEY:			0001750050
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		C/O UOVANT SCIENCES, INC.
		STREET 2:		5151 CALIFORNIA AVENUE, SUITE 250
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92617
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001750050</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001635088</issuerCik>
      <issuerName>Roivant Sciences Ltd.</issuerName>
      <secFileNumber>001-40782</secFileNumber>
      <issuerAddress>
        <com:street1>CLARENDON HOUSE, 2 CHURCH STREET</com:street1>
        <com:city>HAMILTON HM11</com:city>
        <com:stateOrCountry>D0</com:stateOrCountry>
        <com:zipCode>HM11</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>441-295-5950</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Sukhatme Mayukh</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Rockefeller Financial LLC</name>
        <address>
          <com:street1>45 Rockefeller Plaza, Floor 5</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10111</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>689495</noOfUnitsSold>
      <aggregateMarketValue>8277401.46</aggregateMarketValue>
      <noOfUnitsOutstanding>727949744</noOfUnitsOutstanding>
      <approxSaleDate>12/26/2024</approxSaleDate>
      <securitiesExchangeName>Nasdaq</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>12/26/2024</acquiredDate>
      <natureOfAcquisitionTransaction>Option Exercise - Grant date 04/20/2022</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Roivant Sciences LTD</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>689495</amountOfSecuritiesAcquired>
      <paymentDate>12/26/2024</paymentDate>
      <natureOfPayment>Wire</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Mayukh Sukhatme c/o Roivant Sciences Ltd.</name>
        <address>
          <com:street1>7th Floor, 50 Broadway</com:street1>
          <com:city>London</com:city>
          <com:stateOrCountry>X0</com:stateOrCountry>
          <com:zipCode>SW1H 0DB</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Shares</securitiesClassTitle>
      <saleDate>12/23/2024</saleDate>
      <amountOfSecuritiesSold>10796</amountOfSecuritiesSold>
      <grossProceeds>129554.80</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Mayukh Sukhatme c/o Roivant Sciences Ltd.</name>
        <address>
          <com:street1>7th Floor, 50 Broadway</com:street1>
          <com:city>London</com:city>
          <com:stateOrCountry>X0</com:stateOrCountry>
          <com:zipCode>SW1H 0DB</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Shares</securitiesClassTitle>
      <saleDate>12/18/2024</saleDate>
      <amountOfSecuritiesSold>412584</amountOfSecuritiesSold>
      <grossProceeds>4969631.30</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Mayukh Sukhatme c/o Roivant Sciences Ltd.</name>
        <address>
          <com:street1>7th Floor, 50 Broadway,</com:street1>
          <com:city>London</com:city>
          <com:stateOrCountry>X0</com:stateOrCountry>
          <com:zipCode>SW1H 0DB</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Shares</securitiesClassTitle>
      <saleDate>12/24/2024</saleDate>
      <amountOfSecuritiesSold>185946</amountOfSecuritiesSold>
      <grossProceeds>2231699.61</grossProceeds>
    </securitiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>12/26/2024</noticeDate>
      <signature>/s/ Carmen Zamores as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for Sukhatme Mayukh</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
